GLAXOSMITHKLINE PLC 13D/13G Filings for Vir Biotechnology, Inc. (VIR)

GLAXOSMITHKLINE PLC 13D and 13G filings for Vir Biotechnology, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2022-02-10
4:46 pm
Purchase		 2021-12-31 13G Vir Biotechnology, Inc.
VIR		 GLAXOSMITHKLINE PLC 8,550,954
6.500%		 1,924,927increase
(+29.05%)		 Filing
2020-05-04
4:18 pm
Purchase		 2020-04-22 13G Vir Biotechnology, Inc.
VIR		 GLAXOSMITHKLINE PLC 6,626,027
6.030%		 6,626,027increase
(New Position)		 Filing